van der Klis FRM - Search Results

1

Effect of age and season on respiratory mucosal immune marker profiles.

van Woudenbergh E, van Rooijen DM, Veldman-Wolf JJ, Nicolaie MA, Huynen MA, van der Klis FRM, de Jonge MI, den Hartog G. van Woudenbergh E, et al. Among authors: van der klis frm. J Allergy Clin Immunol. 2023 Dec 23:S0091-6749(23)02490-9. doi: 10.1016/j.jaci.2023.12.009. Online ahead of print. J Allergy Clin Immunol. 2023. PMID: 38142822 Free article.

2

Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.

de Voer RM, van der Klis FR, Nooitgedagt JE, Versteegh FG, van Huisseling JC, van Rooijen DM, Sanders EA, Berbers GA. de Voer RM, et al. Clin Infect Dis. 2009 Jul 1;49(1):58-64. doi: 10.1086/599347. Clin Infect Dis. 2009. PMID: 19480581

3

Immunity against poliomyelitis in the Netherlands, assessed in 2006 to 2007: the importance of completing a vaccination series.

van der Maas NA, Mollema L, Berbers GA, van Rooijen DM, van der Avoort HG, Conyn-Van Spaendonck MA, de Melker HE, van der Klis FR. van der Maas NA, et al. Euro Surveill. 2014 Feb 20;19(7):20705. doi: 10.2807/1560-7917.es2014.19.7.20705. Euro Surveill. 2014. PMID: 24576472 Free article.

4

Timing of an adolescent booster after single primary meningococcal serogroup C conjugate immunization at young age; an intervention study among Dutch teenagers.

Stoof SP, van der Klis FR, van Rooijen DM, Knol MJ, Sanders EA, Berbers GA. Stoof SP, et al. PLoS One. 2014 Jun 25;9(6):e100651. doi: 10.1371/journal.pone.0100651. eCollection 2014. PLoS One. 2014. PMID: 24963638 Free PMC article.

5

Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool.

Stoof SP, van der Klis FR, van Rooijen DM, Bogaert D, Trzciński K, Sanders EA, Berbers GA. Stoof SP, et al. Vaccine. 2015 Jul 31;33(32):3933-9. doi: 10.1016/j.vaccine.2015.06.055. Epub 2015 Jun 19. Vaccine. 2015. PMID: 26100925

6

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?

Stoof SP, Buisman AM, van Rooijen DM, Boonacker R, van der Klis FR, Sanders EA, Berbers GA. Stoof SP, et al. PLoS One. 2015 Oct 12;10(10):e0138665. doi: 10.1371/journal.pone.0138665. eCollection 2015. PLoS One. 2015. PMID: 26458006 Free PMC article.

7

Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.

van Ravenhorst MB, Marinovic AB, van der Klis FR, van Rooijen DM, van Maurik M, Stoof SP, Sanders EA, Berbers GA. van Ravenhorst MB, et al. Vaccine. 2016 Dec 7;34(50):6309-6315. doi: 10.1016/j.vaccine.2016.10.049. Epub 2016 Nov 4. Vaccine. 2016. PMID: 27817957

8

Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.

Stoof SP, van Ravenhorst MB, van Rooijen DM, de Voer RM, van der Klis FRM, Boland GJ, Sanders EAM, Berbers GAM, Teunis PF. Stoof SP, et al. Among authors: van der klis frm, van ravenhorst mb, van rooijen dm. Clin Vaccine Immunol. 2017 Feb 6;24(2):e00429-16. doi: 10.1128/CVI.00429-16. Print 2017 Feb. Clin Vaccine Immunol. 2017. PMID: 27881489 Free PMC article.

9

Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Sanders EAM, Berbers GAM. van Ravenhorst MB, et al. Among authors: van der klis frm, van rooijen dm. Vaccine. 2017 Aug 24;35(36):4753-4760. doi: 10.1016/j.vaccine.2017.06.007. Epub 2017 Jun 21. Vaccine. 2017. PMID: 28647167 Clinical Trial.

10

Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.

van Ravenhorst MB, van der Klis FRM, van Rooijen DM, Knol MJ, Stoof SP, Sanders EAM, Berbers GAM. van Ravenhorst MB, et al. Among authors: van der klis frm, van rooijen dm. Vaccine. 2017 Aug 24;35(36):4745-4752. doi: 10.1016/j.vaccine.2017.06.053. Epub 2017 Jun 28. Vaccine. 2017. PMID: 28668575 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page